Oncology Generic Medicines - Additions
Supply of oncology generic medicines to NHS Scotland
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Value
£14,878,505
Published
10 Mar 2020
Closes
14 Apr 2020
Procurement details
Source
Pcs
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 Octreotide Vials (Secondary Care)
£1,709,914
Supply of octreotide vials in a secondary care setting to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Delivery: Scotland
Lot 2 Octreotide Vials (Homecare)
£38,875
Supply of octreotide vials in a homecare setting to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework [to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Delivery: Scotland
Lot 3 Dasatinib Tablets
£5,655,912
Supply of dasatinib tablets to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Delivery: Scotland
Lot 4 Azacitidine Vials and Erlotinib Tablets
£7,473,804
Supply of azacitidine vials and erlotinib tablets to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per line. Full details of Goods and volumes can be found within the ITT documents.
Delivery: Scotland
Documents
Unlock document linkOncology Generic Medicines - Additions
Not provided
Supply of oncology generic medicines to NHS Scotland
Contract notice · Web page
Oncology Generic Medicines - Additions
Not provided
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.